Semiconductor devices with dopant migration suppression and method of fabrication thereof

Information

  • Patent Grant
  • 9112057
  • Patent Number
    9,112,057
  • Date Filed
    Tuesday, September 18, 2012
    12 years ago
  • Date Issued
    Tuesday, August 18, 2015
    9 years ago
Abstract
A method of fabricating a semiconductor device includes providing a substrate having a semiconducting surface and forming a first epitaxial layer on the semiconducting surface. The first epitaxial layer includes a first semiconducting material doped in-situ with at least one dopant of a first conductivity type. The method also includes adding at least one dopant of a second conductivity type into one portion of the substrate to define at least one counter-doped region with an overall doping of the second conductivity type and at least one other region with an overall doping of the first conductivity type in the other portions of substrate. The method further includes forming a second epitaxial layer on the first epitaxial layer, the second epitaxial layer being a second semiconducting material that is substantially undoped.
Description
FIELD OF THE INVENTION

The present invention relates to semiconductor devices and methods of fabrication thereof, and more specifically to semiconductor devices with dopant migration suppression and methods of fabrication thereof.


BACKGROUND

In certain semiconductor devices, a structure is required in which a highly doped layer is disposed adjacent to a layer with a substantially lower doping. In certain cases, this arrangement can be problematic as such structures are potentially susceptible to dopant migration, via diffusion and other mechanisms. For example, when a first layer of silicon doped with boron (B) is formed adjacent to and located underneath a second layer of silicon that is undoped or has a significantly lower B doping concentration than the first layer, unwanted migration of B into the second layer can occur when a thermal treatment is applied during fabrication of the semiconductor device. Similar results have been observed for other dopants in silicon, such as phosphorus (P) and arsenic (As). As a result, the abrupt doping transition between differentially doped layers may be degraded or compromised by subsequent thermal processing. In a worst case, the dopant could diffuse completely through the second layer, altering the undoped nature of the second layer in its entirety. In either case, the electrical characteristics of the semiconductor device can be significantly altered when dopant migration occurs.


In an effort to avoid migration of highly mobile dopants, into undoped regions, development efforts have primarily focused on: (1) reducing the thermal budget during semiconductor device manufacturing processes and (2) the implantation of additional species to form blocking regions to inhibit the migration of dopants. For example, carbon (C) implants activated into substitutional lattice sites (such as by first performing a pre-amorphization followed by C implantation and recrystallization anneal) have been utilized to suppress migration of B and P in silicon.


Both of these efforts (lower thermal budgets and migration inhibitors) have met with some success, but still have drawbacks. With respect to thermal budget reductions, at least some thermal treatments will always be required and therefore the amount of thermal budget reduction is always limited. Additionally, variations in the manufacturing process can limit the effectiveness of the reduced thermal budget. In particular, defects and interstitial/vacancy pairs generated during normal semiconductor device processing can result in migration, even when a lower thermal budget is applied. Moreover, even if thermal budgets are accurately controlled, small amounts of unwanted dopant diffusion can still have a pronounced effect on devices with reduced dimensions or devices designed with low doping concentrations. In addition, some thermal steps can simply lose effectiveness if the temperature is lowered beyond a critical minimum value.


With respect to ion implantation of a migration inhibitor such as carbon, one potential issue is that there can be inaccuracies in the placement of the carbon species, resulting in some dopants being placed in undesirable locations or atoms missing from locations where the dopant diffusion protection is needed. As a result, some migration can occur due to the ineffectiveness of the ion implantation process leading to the imperfect placement of the species intended to suppress migration. Further, ion implantation processes can introduce additional contaminating impurities into the semiconductor device and additional implant damage. Either of these can adversely affect device performance. Moreover, the extra implantation steps can introduce additional costs to the manufacturing process.


In view of the foregoing, there is a need for an alternate approach for suppressing dopant migration in semiconductor devices.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a flow chart of steps in an exemplary method in accordance with the various embodiments of the invention;



FIGS. 2A-2D are various views showing the results during various portions of the method in FIG. 1;



FIGS. 3A-3D are various views showing the results during various portions of an alternate embodiment of the exemplary process flow of FIG. 1; and



FIG. 4 shows the result of the alternate embodiment of the method in FIG. 3.





DETAILED DESCRIPTION

Embodiments are described with reference to the attached figures, wherein like reference numerals are used throughout the figures to designate similar or equivalent elements. The figures are not drawn to scale and they are provided merely to illustrate the embodiments. It should be understood that numerous specific details, relationships, and methods are set forth to provide a full understanding of the embodiments. One having ordinary skill in the relevant art, however, will readily recognize that embodiments can be practiced without one or more of the specific details or with other methods. In other instances, well-known structures or operations are not shown in detail to avoid obscuring the embodiments. Embodiments are not limited by the illustrated ordering of acts or events, as some acts may occur in different orders and/or concurrently with other acts or events. Furthermore, not all illustrated acts or events are required to implement a methodology in accordance with the embodiments.


As noted above, dopant migration is a significant concern in various types of semiconductor devices that include low doped (or undoped) regions abutting highly doped regions. In such devices, electrical characteristics may be dependent on the formation of a sufficiently abrupt transition of dopants between the regions. One example of such a semiconductor device is the deeply depleted channel (DDC) transistor device.


DDC transistors are formed, for example, by forming a doped region in a well for CMOS devices by forming a heavily doped screen layer (5×1018 atoms/cm3 to 1×1020 atoms/cm3). This can be followed by formation of a substantially undoped (that is, a material into which electrically modifying dopants are not purposely introduced) blanket epitaxial layer (<5×1017 atoms/cm3) deposited over the screen layer, extending across multiple die and transistor die blocks.


Details regarding exemplary DDC transistor structures are more completely described in U.S. patent application Ser. No. 12/708,497 titled “ELECTRONIC DEVICES AND SYSTEMS, AND METHODS FOR MAKING AND USING THE SAME” and filed Feb. 18, 2010, U.S. patent application Ser. No. 12/971,884 titled “LOW POWER SEMICONDUCTOR TRANSISTOR STRUCTURE AND METHOD OF FABRICATION THEREOF” and filed Dec. 17, 2010, U.S. patent application Ser. No. 12/971,955 titled “TRANSISTOR WITH THRESHOLD VOLTAGE SET NOTCH AND METHOD OF FABRICATION THEREOF” and filed Dec. 17, 2010, U.S. patent application Ser. No. 12/895,785 titled “ADVANCED TRANSISTORS WITH THRESHOLD VOLTAGE SET DOPANT STRUCTURES” and filed Sep. 30, 2010, and U.S. patent application Ser. No. 12/895,813 titled “ADVANCED TRANSISTORS WITH PUNCH THROUGH SUPPRESSION” and filed Sep. 30, 2010, the disclosures of which are hereby incorporated by reference in their entirety.


Although the various embodiments will be described primarily with respect to DDC transistor devices, the various embodiments are not limited in this regard. That is, the various processes, structures and methods described herein are equally applicable to any other types of semiconductor device structures in which a highly doped region abuts a low doped or substantially undoped region, and there is the potential for migration from the doped region to the undoped region. Examples of devices designed in this manner are, super steep retrograde well devices and other depleted channel devices, or any device channel having heavily doped regions in contact with moderately doped to highly doped regions (such as traditional transistors with LDD or S/D implants adjacent to channel regions).


In depleted channel processes, the heavily doped region, which is called “well”, is typically formed via implantation of dopants. The P-well typically uses B doping. Boron migration issues are typically managed via implantation of C and careful management of thermal budget. In the case of a DDC transistor, an exemplary process flow for forming the screen regions for the DDC NMOS device can begin with B implants into the P-well for the NMOS device regions. These implants are followed by a germanium (Ge) pre-amorphization implant into the NMOS device regions at an energy of about 20 keV to 60 keV and at a dose of about 1×1014 to 1×1015 atoms/cm2. This Ge implant is then followed by a carbon (C) implant into the NMOS device regions at about 2 keV to 7 keV at a dose of about 1×1014 atoms/cm2 to 1×1015 atoms/cm2. Recrystallization anneal(s) are carried out. Separately, screen implants into the N-well for the DDC PMOS device regions, for instance, Sb or As, can be applied.


After at least the DDC NMOS implants are completed, an anneal process can be performed. The anneal process serves two purposes. First, the anneal process provides for recrystallization of the portion of the substrate amorphized by the Ge implants. This recrystallization results in at least some of the implanted C being integrated into the recrystallized substrate substitutionally. The substitutional C, in turn, prevents migration of the B atoms. Second, the anneal process serves to activate the implanted dopants for the DDC device.


The DDC process flow then continues, preferably with the formation of the substantially undoped blanket epitaxial silicon, formation of isolation features, formation of transistors and other devices thereon, and formation of interconnect features.


While the process flow above does provide some suppression of B migration in DDC structures and depleted channel structures, the reliance on an ion implantation-based process has several drawbacks. First, variations in the implant processes and numerous masking steps can result in an imperfect placement of the B and C implants, and their resulting profiles in the recrystallized substrate. For example, the implanted C region may be located below the layer of the implanted B atoms, rendering the C ineffective to prevent upward migration of B.


Second, although the anneal process following Ge pre-amorphization is intended to provide recrystallization of the substrate, such a process may not provide 100% recrystallization of the amorphized and mechanically damaged portions of the substrate. As a result, any defects remaining in the substrate can create leakage paths and reduce device yield. Additionally, such defects may provide migration paths for the B and other dopants into the epitaxial silicon layer as well as providing a source of interstitials and vacancies which can result in increased dopant diffusion coefficients for a given thermal budget.


Finally, as noted above, implant processes are well-known for introducing additional impurities. Such impurities can degrade performance and consequently reduce yields.


In view of the limitations of conventional migration suppression techniques, the various embodiments described below are directed to a process flow for suppressing dopant migration for semiconductor devices that consist of substantially undoped or low doped regions formed on a highly doped substrate. In particular, a process flow in accordance with the various embodiments provides for forming at least a portion of the highly doped regions by epitaxially depositing a layer of semiconductor material on the substrate that incorporates the electrically active dopant species, that is, via in-situ doping of the semiconductor material with the dopant species of concern. For example, in the case of a depleted channel device, this process can involve depositing a layer of B-doped silicon sufficient to form the well on the NMOS device. For the DDC device, this process can include depositing a layer of B-doped silicon with sufficient dopants to form the well and screen region for DDC devices. The advantage of such a configuration is that diffusion of such dopants is limited. In general, in the case of implanted dopants, diffusion is primarily due to the presence of point defects, self-interstitials, and vacancies in the semiconductor material that enhance the diffusivity of dopants such as boron and phosphorus. These “transient enhanced diffusion (TED) mechanisms” allow dopant atoms to more easily traverse the lattice of the semiconductor material during annealing.


The practical result of in-situ doping is that since the dopants are already incorporated into the semiconductor material, an activation anneal for such dopants is not needed. Also, in-situ doping can eliminate many of the point defects that result in TED. Further, even if some additional implants of a same conductivity type are still required to tune the device characteristics, the dopants provided in-situ will be less likely to diffuse during subsequent anneal processes. Therefore, the amount of the dopant available for diffusing into an adjacent undoped or low-doped layer is reduced compared with an all-implant method for introducing dopants into the substrate. An exemplary in-situ process is described below in greater detail with respect to FIGS. 1, 2A, 2B, 2C, and 2D.



FIG. 1 is a flowchart of steps in an exemplary method 100 for fabricating semiconductor devices in accordance with the various embodiments. FIGS. 2A-2D are cross-sections showing the formation of DDC devices in accordance with a particular embodiment of the method described in FIG. 1.


As shown in FIG. 1, the method 100 begins with the formation of a first epitaxial layer on a semiconducting substrate (step 102), where the first epitaxial layer includes at least one electrically active dopant. The dopant is added to the epitaxial process, and by forming the doped region using epitaxial growth, the likelihood of migration is reduced. A cartoon illustration for a DDC embodiment is provided at FIG. 2A-2D. As shown in FIG. 2A, a silicon substrate 202 is provided, on which an in-situ B-doped silicon epitaxial layer (B-doped Si epi) 204 is formed. The surface of B-doped Si epi 204 defines a new surface for the substrate 202.


Optionally, the deposition of the B-doped Si epi 204 can be preceded by an anti-punchthrough (APT) implant into the surface of substrate 202. For example, in the case of a Si-based DDC device, an NMOS APT implant can be provided by implanting B at an energy of about 10 keV to 30 keV at a dose of about 5×1012 atoms/cm2 to 5×1013 atoms/cm2. The B-doped Si epi 204 can then be formed.


In one embodiment, the B-doped Si epi 204 is formed by depositing a blanket layer by way of an epitaxial silicon process. The B doping can be selected to provide an appropriate doping level to define a heavily doped screen region for the P-well side of a to-be-formed device. In DDC embodiments, a B doping concentration between about 5×1018 atoms/cm3 and about 1×1020 atoms/cm3 can be provided, the particular doping concentration selected based upon desired device electrical characteristics of threshold voltage, junction leakage and other parametric considerations. In DDC embodiments, a B-doped Si epi layer of less than 10 nm can be formed, however, the thickness can be as high as 30 nm or more in some embodiments. Such a layer can be deposited using an epitaxial growth process that includes a boron doping source to provide the boron in-situ doping. For example, in particular embodiments, a chemical vapor deposition (CVD) process can be used, where B is provided by way of a suitable precursor gas, such as diborane; while disilane, silane, or dichlorosilane may be selected as the silicon precursor. In one particular embodiment, the epitaxial growth process can utilize processing temperatures of approximately 700C to 900C at a reduced pressure, for instance, 20 Torr.


Although the exemplary embodiments refer primarily to the forming of silicon-comprising layers with in situ B-doping, the various embodiments are not limited in this regard. In other embodiments, the first epitaxial layer can be doped in-situ with another type of electrically active dopant. For example, in the case of silicon-comprising materials, P can be incorporated in-situ in a similar manner as described herein.


Referring back to FIG. 1, once the first epitaxial layer (B-doped Si epi 204) is formed, mask layers and implants can be utilized to apply any additional NMOS implants needed and to apply PMOS doped region implants, as shown in FIGS. 2B and 2C. FIG. 2B illustrates the application of optional additional implants for DDC NMOS devices and FIG. 2C illustrates the formation of doped regions for DDC PMOS devices. For purposes of describing the steps that take place after B-doped Si epi 204 is formed, it is noted that the B-doped Si epi 204 is treated as an extension of the substrate 202.


Optionally, as shown in FIG. 2B, additional implants 208 can be provided as needed to set the threshold voltage (Vth) and define other characteristics for the DDC NMOS devices. As shown in FIG. 2B, any additional NMOS implants can be applied via a process that includes formation of a patterned mask layer 206 to prevent dopants from being implanted into other regions of the substrate 202, such as PMOS regions. For example, as illustrated in FIG. 2B, the masking layer 206 shown as covering the PMOS region, can be formed by providing a layer of photoresist which is patterned with openings to expose the regions of the substrate 202 associated with the NMOS devices. However, the various embodiments are not limited in this regard and the masking layer 206 can be formed using a hard mask layer, alone or in combination with photoresist. Such a hard mask layer can be formed using layers of silicon oxide, silicon nitride, or any other suitable hard mask layers. Optionally, a blanket sacrificial protective oxide layer (not shown) can be formed prior to the formation of the masking layer 206. Such a layer can be an in-situ steam generated (ISSG) layer or any other type of sacrificial oxide layer sufficient to protect the substrate from unwanted effects of subsequent ion implantation. Appropriate implants, such as P-type conductivity implants, are then provided according to the types of the devices to be formed.


For instance, the process may begin with a boron (B) anti-punchthrough implant (if not performed prior to formation of B-doped Si epi 204) at an energy of about 10 keV to 30 keV at a dose of about 5×1012 atoms/cm2 to 5×1013 atoms/cm2, as well as a Boron implant at an energy of about 2 keV to 10 keV at a dose of about 1×1012 atoms/cm2 to 1×1014 atoms/cm2. Combined with the dopants already incorporated into the B-doped Si epi 204, such conditions will be generally suitable for the formation of DDC NMOS low Vth (NLVt) devices. Variations in energy, material, and dose for one or more of the implants discussed above may be applied depending on the specifications from the device design. Further, the implant conditions discussed above are presented solely for purposes of illustration and not by way of limitation. In the various embodiments, more or less implants can be used. Alternatively stated, other implants, other than those described above, can be utilized as well.


In some embodiments, instead of performing such implants, the additional dopants required for the NMOS devices can be added during the growth of the B-doped Si epi 204. For example, by varying the process conditions during growth of the B-doped Si epi 204, such as the ratio of dopant and silicon gases during a CVD process, the doping profile in the B-doped Si epi 204 can be tailored as needed. Accordingly, the well, screen, APT, and any other regions of the NMOS devices can be formed during formation of the B-doped Si epi 204.


Following the completion of the implants discussed above, additional patterned mask layers can be provided to apply additional implants to build out additional types of NMOS devices. For example, different sub-regions can be masked off to allow for preselected implants for the formation of NMOS standard Vth (NSVt) devices, NMOS SRAM devices in different sub-regions overlying the P-well. For each of these different device types, additional screen implants can be provided to change the Vth for each of these device types. NMOS analog devices can also be formed in the P-well by using appropriate implants. The doses and energies are selected to result in a targeted concentration of dopants and depth of doped region to provide a target Vth value for these devices. For instance, additional Boron may be implanted at an energy between about 2 keV to 10 keV at a dose of about 1×1012 to 1×1014 atoms/cm2. However, the various embodiments are not limited to this particular configuration, and the implant conditions may vary as needed to meet the Vth requirements for the device design. The implant conditions for the additional screen implants discussed are provided solely for illustrative purposes. Any suitable set of implants can be used in the various embodiments. Further, different devices can utilize common implants. Accordingly, the masking layers can be configured during the implantation process to allow a same implant to be used for multiple device types.


Once the implants for the NMOS regions are completed, all of the NMOS devices are covered over with a mask so that the doped regions for the PMOS regions can be formed. However, in the various embodiments, the existing blanket B-doped Si epi 204 must be considered when applying such PMOS implants. Specifically, the various embodiments require higher implant doses to provide sufficient counter-doping and provide sufficient N-type doping for the PMOS device. In particular embodiments, the implant doses will need to be high enough to counter the B doping in the B-doped Si epi 204. For example, if the in-situ doping B concentration is 5×1018/cm3, and the final desired n-type concentration is 8×1018/cm3, then the n-type implant dose would need to be tailored to generate a peak concentration of 1.3×1019/cm3 (8×1018/cm3+5×1018/cm3). In this example, the final n-type activation would achieve a compensated 8×1018/cm3 n-type region.


For example, as shown in FIG. 2C, the P-well regions 208 are effectively masked off so that the PMOS device region 212 can be formed. For instance, the DDC process may begin with a phosphorous N-well implant at about 200 keV to 450 keV at a dose of about 5×1012 atoms/cm2 to 1×1014 atoms/cm2. The individual devices can include arsenic or antimony anti-punchthrough implants at an energy of about 50 keV to 200 keV at a dose of about 5×1012 atoms/cm2 to 1×1014 atoms/cm2. A DDC implant, for instance, arsenic at an energy of about 2 keV to 10 keV at a dose of about 2×1012 atoms/cm2 to 2×1014 atoms/cm2 can be used to form the screen/Vt region for the DDC transistor. Variations of energies, materials and doses may apply depending on the target Vth and other specifications for the device design.


Then, optionally, and similar to the process described above with respect to FIG. 2B, additional patterned mask layers can be formed to cover devices to be protected to allow for additional screening implants to be performed for the higher Vth devices which are formed using heavier concentrated regions, such as PMOS standard Vth (PSVt) values, PMOS SRAM devices, and PMOS analog devices. For instance, additional arsenic or antimony may be implanted at an energy of about 2 keV to 10 keV at a dose of about 2×1012 atoms/cm2 to 2×1014 atoms/cm2. The doses and energies are selected to result in a targeted concentration of dopants and depth of doped region to provide target Vth values for each type of device. The masking layers can be configured during the implantation process to allow a same implant to be used for multiple device types. The particular implant materials and conditions provided and the mask patterns presented are provided solely for purposes of illustration and are not intended to limit the various embodiments in any regard.


Referring back to FIG. 1, after the implants are completed for the devices within the P-well 208 and N-well 312 regions (step 104), any remaining photoresist or other mask material and any remaining sacrificial oxide should be removed to expose the semiconducting surface including the implanted regions. Thereafter, the implanted dopants can be activated via an anneal process (step 106).


In the various embodiments, any type of anneal/activation process can be utilized. However, what is significant regarding the various embodiments is that since the Ge amorphization implant is no longer performed, the anneal process no longer requires the use of a regrowth or recrystallization anneal which requires a moderately high to high temperature over an extended period of time. Accordingly, the present disclosure contemplates that the anneal process following the formation of the NMOS and PMOS device regions can be skipped or performed via the use of a relatively low thermal budget anneal, effective to activate any implanted species and repair any local damage caused by the ion implantation.


The result of the foregoing process is that since the amount of B available to diffuse into the Si epi 214 is significantly reduced, the amount of migration into subsequently formed layers is also significantly reduced. Moreover, the higher-dose B implant processes (e.g., APT) are carried out at high energies, resulting in such high dose being located far from the interface between Si epi 214 and B-doped Si epi 204. Further, any additional migration due to the defects from incompletely recrystallized portions of the substrate and due to the thermal budget for recrystallization is no longer a concern.


Referring back to FIG. 1, once the dopants are activated (step 106), a second epitaxial layer 214 that is undoped (that is, does not include in its process conductivity-altering dopants) or doped to a pre-determined concentration can be formed over the B-doped Si epi 204 on the substrate 202 (step 108). The second epitaxial layer 214 can be a blanket layer formed by way of an epitaxial silicon process. The thickness of the second epitaxial layer 214 can be selected based on desired device characteristics. For example, in one particular embodiment, a silicon epitaxial layer between 10 nm and 40 nm, such as 15 nm can be formed. Such a layer can be deposited using an epitaxial growth process, where the processing temperatures, the deposition time, or both are selected such that significant migration of previously implanted material is minimized. In one particular embodiment, the epitaxial growth process can utilize processing temperatures of approximately 600C. However, the various embodiments are not limited in this regard. In other embodiments, depending on process conditions, device targets, and other factors, the thickness and doping levels of the second epitaxial layer 214 can vary.


The present disclosure contemplates that as part of the process of forming devices in active areas or regions of the semiconducting surface, some type of active area isolation is provided. Accordingly, following the formation of the second epitaxial layer 214 (step 108), isolation features can be formed to define different device regions (step 110). The result of this process is illustrated in FIG. 2D. FIG. 2D shows how shallow trench isolation (STI) features 216 can be formed after the formation of second epitaxial layer 214. However, the various embodiments are not limited to STI features and any other types of active area isolation features can be used with the various embodiments. In the various embodiments, the STI features 216 can be used not only to define separate NMOS and PMOS active areas, but additional STI features can be provided to define separate SVT, LVT, SRAM, and analog devices in the PMOS and NMOS device regions. Following the formation of these isolation features, processing of the substrate can then continue on to complete the transistor devices in the PMOS and NMOS device regions (step 112).


In the embodiments described above, the present disclosure contemplates that by reducing the amount of B introduced via implantation, the amount of B interstitials and silicon interstitial/vacancy pairs available to diffuse into the Si epi 214 are reduced. However, in some embodiments, additional NMOS implants may still lead to unwanted B diffusing into the Si epi 214. Moreover, some of the B incorporated into the B-doped Si epi 204 may still diffuse in to the Si epi 214 during anneal processes.


Accordingly, in particular embodiments, a barrier material-enhanced epitaxial layer is contemplated. More specifically, the first epitaxial layer deposited on the substrate can include a barrier material incorporated therein, such as carbon, selected in amounts aimed at suppressing migration of a dopant species. Two alternative exemplary processes are described below with respect to FIGS. 3A-3D.



FIGS. 3A-3D show the result of an alternate embodiment of the exemplary process flow of FIG. 1. The process can begin in a manner substantially similar to that described for FIG. 1. That is, a substrate can be provided and a first epitaxial layer can be formed thereon, as described with respect to step 102. However, in one alternate process, the in-situ doped Si epi includes both B doping and C doping to incorporate C into the B:Si epitaxial layer to inhibit migration of the boron. As shown in FIG. 3A, a silicon substrate 302 can be provided and thereafter a B-doped C:Si epi layer 304 can be formed. The B doping can be selected to provide an appropriate doping level to define the needed doping levels for the NMOS region, including the desired concentration for screen region in the case of a DDC transistor, as previously described.


The amount of C incorporated substitutionally into the silicon epitaxial layer can vary. In one particular embodiment, the substitutional C concentration can be selected such that it is less than or equal to 1% in silicon. For example, the concentration of substitutional C may typically be selected to be in the range of between about 1×1019 atoms/cm3 and about 1×1021 atoms/cm3. The B-doped C:Si epi 304 can be formed by introducing a C doping source in-situ into the B in situ-doped epitaxial process, and forming a blanket layer. In particular embodiments, a B-doped C:Si epi layer of less than 5 nm can be formed, however, the thickness can be as high as 20 nm or more in some embodiments. Such a layer can be deposited using a single epitaxial growth process. For example, in particular embodiments, a chemical vapor deposition (CVD) process can be used, where C is provided by way of a suitable precursor gas, such as methylsilane, and B is provided by way of a suitable precursor gas, such as diborane. In one particular embodiment, the epitaxial growth process can utilize processing temperatures of approximately 750C.


The result of the foregoing process is that not only are NMOS regions defined via an epitaxial deposition process rather than via implants, but subsequent B migration from the B-doped C:Si epi 304 is suppressed through the incorporation of C into the layer. As described above, the B doping can be selected such that no additional implants are needed for NMOS devices. However, as described above, the present disclosure also contemplates that some additional B implants may be needed for some types of devices. Thus additional masking and implants can be required, as illustrated in FIG. 3B and as described above with respect to FIG. 2B. That is, a patterned masking layer 306 can be defined (and optionally a sacrificial oxide) and implants for the additional NMOS devices 308 can be applied. As shown in FIG. 3B, the masking layer 306 can be photoresist. However, as noted above, other masking layers can be utilized as well to subdivide the device regions to form discrete additional devices of varying Vth levels by way of additional implants all performed prior to a subsequently deposited substantially undoped epitaxial Si layer.


Once the NMOS region 308 is formed, via formation of B-doped C:Si epi 304 alone or in combination with one or more implants, the PMOS region 312 can be formed, as shown in FIG. 3C. This process can be performed in substantially the same manner as described above with respect to FIGS. 2A-2D. That is, a patterned masking layer 310 can be defined (and optionally a sacrificial oxide) and implants for PMOS devices 312 can be applied. As shown in FIG. 3C, the masking layer 310 can be photoresist. However, as noted above, other masking layers can be utilized as well.


As noted above, the presence of the blanket B-doped C:Si epi 304 will require different implant doses for the PMOS region than those previously described. Specifically, higher implant doses will be required in order to provide sufficient counter-doping to the in-situ B doping and provide sufficient N-type doping for the PMOS region. In particular embodiments, the implant doses will need to be high enough to counter the B doping in the B-doped Si epi 304. For example, if the in-situ doping B concentration is 5×1018/cm3, and the final desired n-type concentration is 8×1018 atoms/cm3, then the n-type implant dose would need to be tailored to generate a peak concentration of 1.3×1019/cm3 (=8×1018+5×1018). In this example, the final n-type activation would achieve a compensated 8×1018/cm3 n-type region.


After the implants are completed for the device regions 308 and 312, any remaining photoresist or other mask material (and any remaining sacrificial oxide) should be removed to expose the semiconducting surface including the implanted regions. The implanted dopants can then be activated via an anneal process, though without a recrystallization anneal, as previously described. Finally, the second epitaxial layer 314 and isolation features 316 can be formed, as discussed above with respect to FIGS. 2A-2D. For example, as shown in FIG. 3D, a silicon comprising epitaxial layer 314 can be formed, followed by formation of STI features 316. The process can then proceed to the building of devices in the P-well 308 and N-well 312 regions.


A further alternative process is, instead of incorporating the carbon into the in-situ doped B epitaxial process, to carry out the B in-situ doped epitaxial process first, and then follow with a C in-situ doped epitaxial process. An extra layer of epitaxial material is therefore contemplated, the in-situ B doped epitaxial layer, the in-situ C doped epitaxial layer and the substantially undoped epitaxial layer formed preferably after the NMOS and PMOS device regions have been doped. If a C in-situ doped epitaxial layer is used, then the C concentration is selected so that the C is effective to inhibit migration of doped species in particular, boron, while keeping the thickness of the C in-situ doped epitaxial layer to a minimum. The thickness of the C in-situ doped epitaxial layer can be as little as 5 nm or less, but may need to be thicker to ensure the effectiveness of the layer to inhibit diffusion. Following the deposition of the C in-situ doped epitaxial layer, the substantially undoped epitaxial silicon layer can be formed. Advantageously, by the process described in this embodiment, the C-doped region is restricted to the bottom portion of the transistor channel. The substantially undoped epitaxial silicon layer can remain such and be devoid of carbon constituents. In this example, the final thickness of the undoped epitaxial silicon layer can be adjusted to take into account the thickness of the C doped diffusion inhibiting layer. For example, if the C doped layer were 5 nm, and the final desired thickness of the channel were 25 nm, then 20 nm of undoped epitaxial silicon can be grown over the 5 nm carbon doped layer giving rise to a 25 nm channel region free from intentional n-type or p-type dopants. The described process incorporating a separate C in-situ doped epitaxial layer can be used in combination with a C-doped in situ-B epitaxial layer underneath as well.


The various embodiments described above contemplate that the B and C incorporated in-situ will result in a profile of B and C along a vertical direction normal to the substrate 302 in which the amount of C and B is approximately the same or equal throughout the thickness of the B-doped C:Si epi 304. As used herein, the terms “approximately the same” or “approximately equal” refer to the measurement being compared as having a relative difference of 10% or less. In some embodiments, the amount of C, B, or both can vary along the thickness of the B-doped C:Si epi 304. That is, the amount of C or B can vary along a vertical direction normal to the substrate 302 such that the amount of C, B, or both is not approximately the same along this vertical direction. For example, as shown in FIG. 4, the C-doped portion can be restricted only to a portion of the B-doped C:Si epi 304. FIG. 4 is an alternate view of FIG. 3C, in which the silicon epitaxial layer is not uniform, after STI formation. As shown in FIG. 4, the C comprising portion of the B-doped C:Si epi 304 is restricted to the upper portion of the layer. For example, this can be the first 5-40 nm of the layer. The remaining portion of the layer can then be substantially free of C. Thus, B-doped C:Si epi 304 is formed by first defining a B-doped portion (B-doped Si Epi 304B) and a C comprising portion (C:Si Epi 304A). Such a structure can be achieved during a silicon epitaxial process by separate deposition processes or via adjustment of the ratios of silicon, C, and B precursor gases and other parameters during a single deposition process. In some embodiments, both portions 304A and 304B can be B-doped. In other embodiments, only portion 304B is B-doped. Further, the amount of C or B in each of these portions can also be varied.


The present disclosure also contemplates that in some cases, it may be undesirable to include a C-comprising portion for certain types of devices. For instance, whereas C incorporation is important to inhibit B migration on the NMOS side, the presence of C anywhere in the PMOS region may be problematic. If it is desired to exclude C in the PMOS regions, then, after forming the blanket B-doped Si epitaxial layer and the subsequent blanket C-doped Si epitaxial layer, then the NMOS regions can be masked leaving the PMOS regions exposed, whereupon a selective etch process can be used to remove the in-situ C-doped layer from the PMOS region. This etching can be performed as follows. First, a patterned masking layer can be formed to expose the regions of C-comprising portions to be etched. In some embodiments, the masking layer can consisting of a single layer of photoresist. In other embodiments, the masking layer can consist of a hard mask, separately or in combination with the photoresist layer. Such a hard mask can be a layer of silicon oxide, silicon nitride, or any other material which will be resistant to the removal process to be used for the epitaxial layer.


Once the pattern is formed, a selective removal process is utilized to reduce the thickness of the C-comprising portions. As used herein, the term “selective removal process” refers to any type of removal process that preferentially removes one type of material over another type of material. This can include, but is not limited to, any type of wet or dry, chemical, physical, or plasma-based etch processes for removing materials. In the case of C:Si epi, the selective removal process would be configured to preferentially remove C:Si epi over photoresist material and other masking materials. As noted above, the specific process for the selective removal process can vary depending on the amount of material to be removed and the amount of epitaxial layer thickness variability permitted. After the selective removal process is performed, the photoresist or other masking layer can be removed to expose the surfaces of the semiconducting surface.


This etching process can be performed at various points in the method of FIG. 1. In some embodiments, this process can occur prior to implants being performed (i.e., before step 104). In other embodiments, this process can occur after the implants, but prior to the formation of the second epitaxial layer (i.e., before step 108). Preferably, the selective etching of the C-containing portion should be performed prior to implanting the PMOS region with the N-type dopants. The exact point at which such a process is performed can vary depending on the desired device characteristics. Note that a further alternative to selective etching process is to use selective etching to remove B-containing layers from the PMOS side as well. A consequence of this selective etching is that the height of the substantially undoped epitaxial silicon layer will vary across the surface of the substrate. If desired, the substantially undoped epitaxial layer can be grown and/or then polished back to maintain a substantially planar top surface. Another alternative technique to selectively etching the carbon doped epitaxial material from PMOS devices could be to deposit the carbon doped epitaxial material selectively on the NMOS device regions. The in-situ doping and implant doses need to be adjusted to accommodate the expected final thickness of the substantially undoped epitaxial layer so that Vth can be set accurately. In the event that further Vth tuning is desired, channel implants or pocket implants known as “halo” following the formation of the substantially undoped epitaxial layer can be used.


While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Numerous changes to the disclosed embodiments can be made in accordance with the disclosure herein without departing from the spirit or scope of the invention. Thus, the breadth and scope of the present invention should not be limited by any of the above described embodiments. Rather, the scope of the invention should be defined in accordance with the following claims and their equivalents.


Although the embodiments have been illustrated and described with respect to one or more implementations, equivalent alterations and modifications will occur to others skilled in the art upon the reading and understanding of this specification and the annexed drawings. In addition, while a particular feature may have been disclosed with respect to only one of several implementations, such feature may be combined with one or more other features of the other implementations as may be desired and advantageous for any given or particular application.


The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Furthermore, to the extent that the terms “including”, “includes”, “having”, “has”, “with”, or variants thereof are used in either the detailed description and/or the claims, such terms are intended to be inclusive in a manner similar to the term “comprising.”


Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

Claims
  • 1. A method of fabricating a semiconductor device, comprising: providing a substrate having a semiconducting surface;forming a first epitaxial layer on the semiconducting surface, the first epitaxial layer comprising a first semiconducting material doped in-situ with one or more first dopants to provide a first doping concentration throughout a thickness of the first epitaxial layer corresponding to at least a doping concentration for a MOSFET well region of a first conductivity type and that is different from a doping concentration of the semiconducting surface;adding one or more second dopants into one portion of the first epitaxial layer to define at least one counter-doped region extending through the thickness of the first epitaxial layer and having a second doping concentration corresponding to a doping concentration for a MOSFET well region of the second conductivity type and that is different from the doping concentration of the semiconducting surface; andforming a second epitaxial layer on the first epitaxial layer, the second epitaxial layer comprising a second semiconducting material that is substantially undoped.
  • 2. The method of claim 1, wherein the step forming of the first epitaxial layer comprises incorporating at least one migration inhibiting material into the semiconducting material in situ.
  • 3. The method of claim 1, further comprising the step of forming at least one electrical isolation feature extending through at least the first epitaxial layer and the second epitaxial layer to define a plurality of regions for a plurality of devices.
  • 4. The method of claim 1, further comprising the step of forming a third epitaxial layer between the first epitaxial layer and the second epitaxial layer, the third epitaxial layer comprising semiconducting material incorporating at least one migration inhibiting material into the semiconducting material in-situ.
  • 5. The method of claim 1, further comprising: prior to the forming of the second epitaxial layer, adding, via an ex-situ process, at least one additional dopant of the first conductivity type into at least a portion of the other regions outside the at least one counter-doped region.
  • 6. The method of claim 1, wherein the forming of the first epitaxial layer comprises selecting the first doping concentration to be substantially uniform throughout the first epitaxial layer.
  • 7. The method of claim 1, wherein the first semiconductor material and the second semiconductor material comprise silicon.
  • 8. A method of fabricating a semiconductor device, comprising: providing a substrate having a silicon-comprising surface;forming a first epitaxial layer extending across the surface of the substrate, the first epitaxial layer comprising silicon-comprising material doped in-situ with one or more first dopants to provide a first doping concentration throughout a thickness of the first epitaxial layer corresponding to at least a doping concentration for a MOSFET well region of a first conductivity type and that is different from a doping concentration of the silicon-comprising surface;implanting one or more second dopants into a portion of the first epitaxial layer to define at least one counter-doped region throughout the thickness of the first epitaxial layer having a second doping concentration corresponding to a doping concentration for a MOSFET well region of the second conductivity type and that is different from a doping concentration of the silicon-comprising surface;forming a second epitaxial layer extending over the first epitaxial layer, the second epitaxial layer comprising substantially undoped semiconductor material; andforming at least one isolation feature extending through at least the first epitaxial layer and the second epitaxial layer to define at least one MOSFET device area of the second conductivity type from the at least one counter-doped region and at least one MOSFET device area of the first conductivity type from other regions outside the at least one counter-doped region.
  • 9. The method of claim 8, wherein the forming of the first epitaxial layer comprises in-situ incorporation of carbon into at least one barrier portion of the first epitaxial layer.
  • 10. The method of claim 9, wherein the at least one barrier portion is disposed substantially at an interface of the first epitaxial layer and the second epitaxial region.
  • 11. The method of claim 8, wherein the at least one barrier portion is substantially free of the at least one dopant of the first conductivity type.
  • 12. The method of claim 8, wherein at least one of the first dopants comprises boron.
  • 13. The method of claim 8, further comprising: prior to the forming of the second epitaxial layer, adding, via an ex-situ process, at least one additional dopant of the first conductivity type into at least a portion of the other regions outside the at least one counter-doped region.
  • 14. A method of fabricating a semiconductor device, comprising: providing a substrate having a silicon surface;forming a first epitaxial layer on the silicon surface, the first epitaxial layer comprising silicon doped in-situ with at least boron and having a doping concentration throughout a thickness of the first epitaxial layer corresponding to a doping concentration for a P-type well region for a NFET device and that is different from a doping concentration of the silicon surface;adding an amount of at least one N-type dopant into a portion of the substrate first epitaxial layer to define at least one counter-doped region having a doping concentration throughout the thickness of the first epitaxial layer corresponding to a doping concentration for a N-type well region for a PFET device and that is different from the doping concentration of the silicon surface;forming a second epitaxial layer on the first epitaxial layer, the second epitaxial layer comprising substantially undoped silicon; andforming at least one isolation feature extending through at least the first epitaxial layer and the second epitaxial layer to define at least one PFET device region in the at least one counter-doped region and at least one NFET device region outside the at least one counter-doped region.
  • 15. The method of claim 14, wherein the forming of the first epitaxial layer comprises in-situ incorporation of carbon into at least one barrier portion of the first epitaxial layer.
  • 16. The method of claim 15, wherein the at least one barrier portion is disposed substantially at an interface of the first epitaxial layer and the second epitaxial region.
  • 17. The method of claim 15, wherein the at least one barrier portion is substantially free of boron.
  • 18. The method of claim 14, further comprising: prior to the forming of the second epitaxial layer, adding, via an ex-situ process, at least one additional P-type dopant into at least a portion of the other regions outside the at least one counter-doped region.
  • 19. The method of claim 14, wherein the forming of the first epitaxial layer comprises selecting an amount of the boron to be approximately the same throughout the first epitaxial layer in a direction normal to the silicon surface.
US Referenced Citations (527)
Number Name Date Kind
3958266 Athanas May 1976 A
4000504 Berger Dec 1976 A
4021835 Etoh et al. May 1977 A
4242691 Kotani et al. Dec 1980 A
4276095 Beilstein, Jr. et al. Jun 1981 A
4315781 Henderson Feb 1982 A
4518926 Swanson May 1985 A
4559091 Allen et al. Dec 1985 A
4578128 Mundt et al. Mar 1986 A
4617066 Vasudev Oct 1986 A
4662061 Malhi May 1987 A
4761384 Neppl et al. Aug 1988 A
4780748 Cunningham et al. Oct 1988 A
4819043 Yazawa et al. Apr 1989 A
4885477 Bird et al. Dec 1989 A
4908681 Nishida et al. Mar 1990 A
4945254 Robbins Jul 1990 A
4956311 Liou et al. Sep 1990 A
5034337 Mosher et al. Jul 1991 A
5144378 Hikosaka Sep 1992 A
5156989 Williams et al. Oct 1992 A
5156990 Mitchell Oct 1992 A
5166765 Lee et al. Nov 1992 A
5208473 Komori et al. May 1993 A
5294821 Iwamatsu Mar 1994 A
5298763 Shen et al. Mar 1994 A
5369288 Usuki Nov 1994 A
5373186 Schubert et al. Dec 1994 A
5384476 Nishizawa et al. Jan 1995 A
5426328 Yilmaz et al. Jun 1995 A
5444008 Han et al. Aug 1995 A
5552332 Tseng et al. Sep 1996 A
5559368 Hu et al. Sep 1996 A
5608253 Liu et al. Mar 1997 A
5622880 Burr et al. Apr 1997 A
5624863 Helm et al. Apr 1997 A
5625568 Edwards et al. Apr 1997 A
5641980 Yamaguchi et al. Jun 1997 A
5663583 Matloubian et al. Sep 1997 A
5712501 Davies et al. Jan 1998 A
5719422 Burr et al. Feb 1998 A
5726488 Watanabe et al. Mar 1998 A
5726562 Mizuno Mar 1998 A
5731626 Eaglesham et al. Mar 1998 A
5736419 Naem Apr 1998 A
5753555 Hada May 1998 A
5754826 Gamal et al. May 1998 A
5756365 Kakumu May 1998 A
5763921 Okumura et al. Jun 1998 A
5780899 Hu et al. Jul 1998 A
5847419 Imai et al. Dec 1998 A
5856003 Chiu Jan 1999 A
5861334 Rho Jan 1999 A
5877049 Liu et al. Mar 1999 A
5885876 Dennen Mar 1999 A
5889315 Farrenkopf et al. Mar 1999 A
5895954 Yasumura et al. Apr 1999 A
5899714 Farrenkopf et al. May 1999 A
5918129 Fulford, Jr. et al. Jun 1999 A
5923067 Voldman Jul 1999 A
5923987 Burr Jul 1999 A
5936868 Hall Aug 1999 A
5946214 Heavlin et al. Aug 1999 A
5985705 Seliskar Nov 1999 A
5989963 Luning et al. Nov 1999 A
6001695 Wu Dec 1999 A
6020227 Bulucea Feb 2000 A
6043139 Eaglesham et al. Mar 2000 A
6060345 Hause et al. May 2000 A
6060364 Maszara et al. May 2000 A
6066533 Yu May 2000 A
6072217 Burr Jun 2000 A
6087210 Sohn Jul 2000 A
6087691 Hamamoto Jul 2000 A
6088518 Hsu Jul 2000 A
6091286 Blauschild Jul 2000 A
6096611 Wu Aug 2000 A
6103562 Son et al. Aug 2000 A
6121153 Kikkawa Sep 2000 A
6147383 Kuroda Nov 2000 A
6153920 Gossmann et al. Nov 2000 A
6157073 Lehongres Dec 2000 A
6175582 Naito et al. Jan 2001 B1
6184112 Maszara et al. Feb 2001 B1
6190979 Radens et al. Feb 2001 B1
6194259 Nayak et al. Feb 2001 B1
6198157 Ishida et al. Mar 2001 B1
6218892 Soumyanath et al. Apr 2001 B1
6218895 De et al. Apr 2001 B1
6221724 Yu et al. Apr 2001 B1
6229188 Aoki et al. May 2001 B1
6232164 Tsai et al. May 2001 B1
6235597 Miles May 2001 B1
6245618 An et al. Jun 2001 B1
6268640 Park et al. Jul 2001 B1
6271070 Kotani et al. Aug 2001 B2
6271551 Schmitz et al. Aug 2001 B1
6288429 Iwata et al. Sep 2001 B1
6297132 Zhang et al. Oct 2001 B1
6300177 Sundaresan et al. Oct 2001 B1
6300209 Oh Oct 2001 B1
6313489 Letavic et al. Nov 2001 B1
6319799 Ouyang et al. Nov 2001 B1
6320222 Forbes et al. Nov 2001 B1
6323525 Noguchi et al. Nov 2001 B1
6326666 Bernstein et al. Dec 2001 B1
6335233 Cho et al. Jan 2002 B1
6358806 Puchner Mar 2002 B1
6380019 Yu et al. Apr 2002 B1
6391752 Colinge et al. May 2002 B1
6426260 Hshieh Jul 2002 B1
6426279 Huster et al. Jul 2002 B1
6432754 Assaderaghi et al. Aug 2002 B1
6444550 Hao et al. Sep 2002 B1
6444551 Ku et al. Sep 2002 B1
6449749 Stine Sep 2002 B1
6461920 Shirahata Oct 2002 B1
6461928 Rodder Oct 2002 B2
6472278 Marshall et al. Oct 2002 B1
6482714 Hieda et al. Nov 2002 B1
6489224 Burr Dec 2002 B1
6492232 Tang et al. Dec 2002 B1
6500739 Wang et al. Dec 2002 B1
6503801 Rouse et al. Jan 2003 B1
6503805 Wang et al. Jan 2003 B2
6506640 Ishida et al. Jan 2003 B1
6518623 Oda et al. Feb 2003 B1
6521470 Lin et al. Feb 2003 B1
6534373 Yu Mar 2003 B1
6541328 Whang et al. Apr 2003 B2
6541829 Nishinohara et al. Apr 2003 B2
6548842 Bulucea et al. Apr 2003 B1
6551885 Yu Apr 2003 B1
6552377 Yu Apr 2003 B1
6573129 Hoke et al. Jun 2003 B2
6576535 Drobny et al. Jun 2003 B2
6600200 Lustig et al. Jul 2003 B1
6620671 Wang et al. Sep 2003 B1
6624488 Kim Sep 2003 B1
6627473 Oikawa et al. Sep 2003 B1
6630710 Augusto Oct 2003 B1
6660605 Liu Dec 2003 B1
6662350 Fried et al. Dec 2003 B2
6667200 Sohn et al. Dec 2003 B2
6670260 Yu et al. Dec 2003 B1
6693333 Yu Feb 2004 B1
6730568 Sohn May 2004 B2
6737724 Hieda et al. May 2004 B2
6743291 Ang et al. Jun 2004 B2
6743684 Liu Jun 2004 B2
6751519 Satya et al. Jun 2004 B1
6753230 Sohn et al. Jun 2004 B2
6760900 Rategh et al. Jul 2004 B2
6770944 Nishinohara et al. Aug 2004 B2
6787424 Yu Sep 2004 B1
6797553 Adkisson et al. Sep 2004 B2
6797602 Kluth et al. Sep 2004 B1
6797994 Hoke et al. Sep 2004 B1
6808004 Kamm et al. Oct 2004 B2
6808994 Wang Oct 2004 B1
6813750 Usami et al. Nov 2004 B2
6821825 Todd et al. Nov 2004 B2
6821852 Rhodes Nov 2004 B2
6822297 Nandakumar et al. Nov 2004 B2
6831292 Currie et al. Dec 2004 B2
6835639 Rotondaro et al. Dec 2004 B2
6852602 Kanzawa et al. Feb 2005 B2
6852603 Chakravarthi et al. Feb 2005 B2
6881641 Wieczorek et al. Apr 2005 B2
6881987 Sohn Apr 2005 B2
6891439 Jachne et al. May 2005 B2
6893947 Martinez et al. May 2005 B2
6900519 Cantell et al. May 2005 B2
6901564 Stine et al. May 2005 B2
6916698 Mocuta et al. Jul 2005 B2
6917237 Tschanz et al. Jul 2005 B1
6927463 Iwata et al. Aug 2005 B2
6928128 Sidiropoulos Aug 2005 B1
6930007 Bu et al. Aug 2005 B2
6930360 Yamauchi et al. Aug 2005 B2
6957163 Ando Oct 2005 B2
6963090 Passlack et al. Nov 2005 B2
6972223 Weimer et al. Dec 2005 B2
6995397 Yamashita et al. Feb 2006 B2
7002214 Boyd et al. Feb 2006 B1
7008836 Algotsson et al. Mar 2006 B2
7013359 Li Mar 2006 B1
7015546 Herr et al. Mar 2006 B2
7015741 Tschanz et al. Mar 2006 B2
7022559 Barnak et al. Apr 2006 B2
7036098 Eleyan et al. Apr 2006 B2
7038258 Liu et al. May 2006 B2
7039881 Regan May 2006 B2
7045456 Murto et al. May 2006 B2
7057216 Ouyang et al. Jun 2006 B2
7061058 Chakravarthi et al. Jun 2006 B2
7064039 Liu Jun 2006 B2
7064399 Babcock et al. Jun 2006 B2
7071103 Chan et al. Jul 2006 B2
7078325 Curello et al. Jul 2006 B2
7078776 Nishinohara et al. Jul 2006 B2
7089513 Bard et al. Aug 2006 B2
7089515 Hanafi et al. Aug 2006 B2
7091093 Noda et al. Aug 2006 B1
7105399 Dakshina-Murthy et al. Sep 2006 B1
7109099 Tan et al. Sep 2006 B2
7119381 Passlack Oct 2006 B2
7122411 Mouli Oct 2006 B2
7127687 Signore Oct 2006 B1
7132323 Haensch et al. Nov 2006 B2
7169675 Tan et al. Jan 2007 B2
7170120 Datta et al. Jan 2007 B2
7176137 Perng et al. Feb 2007 B2
7186598 Yamauchi et al. Mar 2007 B2
7189627 Wu et al. Mar 2007 B2
7199430 Babcock et al. Apr 2007 B2
7202517 Dixit et al. Apr 2007 B2
7208354 Bauer Apr 2007 B2
7211871 Cho May 2007 B2
7221021 Wu et al. May 2007 B2
7223646 Miyashita et al. May 2007 B2
7226833 White et al. Jun 2007 B2
7226843 Weber et al. Jun 2007 B2
7230680 Fujisawa et al. Jun 2007 B2
7235822 Li Jun 2007 B2
7256639 Koniaris et al. Aug 2007 B1
7259428 Inaba Aug 2007 B2
7260562 Czajkowski et al. Aug 2007 B2
7294877 Rueckes et al. Nov 2007 B2
7297994 Wieczorek et al. Nov 2007 B2
7301208 Handa et al. Nov 2007 B2
7304350 Misaki Dec 2007 B2
7307471 Gammie et al. Dec 2007 B2
7312500 Miyashita et al. Dec 2007 B2
7323754 Ema et al. Jan 2008 B2
7332439 Lindert et al. Feb 2008 B2
7339215 Chidambaram Mar 2008 B2
7348629 Chu et al. Mar 2008 B2
7354833 Liaw Apr 2008 B2
7380225 Joshi et al. May 2008 B2
7398497 Sato et al. Jul 2008 B2
7402207 Besser et al. Jul 2008 B1
7402872 Murthy et al. Jul 2008 B2
7416605 Zollner et al. Aug 2008 B2
7427788 Li et al. Sep 2008 B2
7442971 Wirbeleit et al. Oct 2008 B2
7449733 Inaba et al. Nov 2008 B2
7462908 Bol et al. Dec 2008 B2
7469164 Du-Nour Dec 2008 B2
7470593 Rouh et al. Dec 2008 B2
7485536 Jin et al. Feb 2009 B2
7487474 Ciplickas et al. Feb 2009 B2
7491988 Tolchinsky et al. Feb 2009 B2
7494861 Chu et al. Feb 2009 B2
7496862 Chang et al. Feb 2009 B2
7496867 Turner et al. Feb 2009 B2
7498637 Yamaoka et al. Mar 2009 B2
7501324 Babcock et al. Mar 2009 B2
7503020 Allen et al. Mar 2009 B2
7507999 Kusumoto et al. Mar 2009 B2
7514766 Yoshida Apr 2009 B2
7521323 Surdeanu et al. Apr 2009 B2
7524740 Liu et al. Apr 2009 B1
7531393 Doyle et al. May 2009 B2
7531836 Liu et al. May 2009 B2
7538364 Twynam May 2009 B2
7538412 Schulze et al. May 2009 B2
7553717 Chakravarthi et al. Jun 2009 B2
7562233 Sheng et al. Jul 2009 B1
7564105 Chi et al. Jul 2009 B2
7566600 Mouli Jul 2009 B2
7569456 Ko et al. Aug 2009 B2
7586322 Xu et al. Sep 2009 B1
7592241 Takao Sep 2009 B2
7595243 Bulucea et al. Sep 2009 B1
7598142 Ranade et al. Oct 2009 B2
7605041 Ema et al. Oct 2009 B2
7605060 Meunier-Beillard et al. Oct 2009 B2
7605429 Bernstein et al. Oct 2009 B2
7608496 Chu Oct 2009 B2
7615802 Elpelt et al. Nov 2009 B2
7622341 Chudzik et al. Nov 2009 B2
7638380 Pearce Dec 2009 B2
7642140 Bae et al. Jan 2010 B2
7644377 Saxe et al. Jan 2010 B1
7645665 Kubo et al. Jan 2010 B2
7651920 Siprak Jan 2010 B2
7655523 Babcock et al. Feb 2010 B2
7673273 Madurawe et al. Mar 2010 B2
7675126 Cho Mar 2010 B2
7675317 Perisetty Mar 2010 B2
7678631 Murthy et al. Mar 2010 B2
7678638 Chu et al. Mar 2010 B2
7681628 Joshi et al. Mar 2010 B2
7682887 Dokumaci et al. Mar 2010 B2
7683442 Burr et al. Mar 2010 B1
7696000 Liu et al. Apr 2010 B2
7704822 Jeong Apr 2010 B2
7704844 Zhu et al. Apr 2010 B2
7709828 Braithwaite et al. May 2010 B2
7723750 Zhu et al. May 2010 B2
7737472 Kondo et al. Jun 2010 B2
7741138 Cho Jun 2010 B2
7741200 Cho et al. Jun 2010 B2
7745270 Shah et al. Jun 2010 B2
7750374 Capasso et al. Jul 2010 B2
7750381 Hokazono et al. Jul 2010 B2
7750405 Nowak Jul 2010 B2
7750682 Bernstein et al. Jul 2010 B2
7755144 Li et al. Jul 2010 B2
7755146 Helm et al. Jul 2010 B2
7759206 Luo et al. Jul 2010 B2
7759714 Itoh et al. Jul 2010 B2
7761820 Berger et al. Jul 2010 B2
7795677 Bangsaruntip et al. Sep 2010 B2
7808045 Kawahara et al. Oct 2010 B2
7808410 Kim et al. Oct 2010 B2
7811873 Mochizuki Oct 2010 B2
7811881 Cheng et al. Oct 2010 B2
7818702 Mandelman et al. Oct 2010 B2
7821066 Lebby et al. Oct 2010 B2
7829402 Matocha et al. Nov 2010 B2
7831873 Trimberger et al. Nov 2010 B1
7846822 Seebauer et al. Dec 2010 B2
7855118 Hoentschel et al. Dec 2010 B2
7859013 Chen et al. Dec 2010 B2
7863163 Bauer Jan 2011 B2
7867835 Lee et al. Jan 2011 B2
7883977 Babcock et al. Feb 2011 B2
7888205 Herner et al. Feb 2011 B2
7888747 Hokazono Feb 2011 B2
7895546 Lahner et al. Feb 2011 B2
7897495 Ye et al. Mar 2011 B2
7906413 Cardone et al. Mar 2011 B2
7906813 Kato Mar 2011 B2
7910419 Fenouillet-Beranger et al. Mar 2011 B2
7919791 Flynn et al. Apr 2011 B2
7926018 Moroz et al. Apr 2011 B2
7935984 Nakano May 2011 B2
7941776 Majumder et al. May 2011 B2
7945800 Gomm et al. May 2011 B2
7948008 Liu et al. May 2011 B2
7952147 Ueno et al. May 2011 B2
7960232 King et al. Jun 2011 B2
7960238 Kohli et al. Jun 2011 B2
7968400 Cai Jun 2011 B2
7968411 Williford Jun 2011 B2
7968440 Seebauer Jun 2011 B2
7968459 Bedell et al. Jun 2011 B2
7989900 Haensch et al. Aug 2011 B2
7994573 Pan Aug 2011 B2
8004024 Furukawa et al. Aug 2011 B2
8012827 Yu et al. Sep 2011 B2
8029620 Kim et al. Oct 2011 B2
8039332 Bernard et al. Oct 2011 B2
8046598 Lee Oct 2011 B2
8048791 Hargrove et al. Nov 2011 B2
8048810 Tsai et al. Nov 2011 B2
8051340 Cranford, Jr. et al. Nov 2011 B2
8053340 Colombeau et al. Nov 2011 B2
8063466 Kurita Nov 2011 B2
8067279 Sadra et al. Nov 2011 B2
8067280 Wang et al. Nov 2011 B2
8067302 Li Nov 2011 B2
8076719 Zeng et al. Dec 2011 B2
8097529 Krull et al. Jan 2012 B2
8103983 Agarwal et al. Jan 2012 B2
8105891 Yeh et al. Jan 2012 B2
8106424 Schruefer Jan 2012 B2
8106481 Rao Jan 2012 B2
8110487 Griebenow et al. Feb 2012 B2
8114761 Mandrekar et al. Feb 2012 B2
8119482 Bhalla et al. Feb 2012 B2
8120069 Hynecek Feb 2012 B2
8129246 Babcock et al. Mar 2012 B2
8129797 Chen et al. Mar 2012 B2
8134159 Hokazono Mar 2012 B2
8143120 Kerr et al. Mar 2012 B2
8143124 Challa et al. Mar 2012 B2
8143678 Kim et al. Mar 2012 B2
8148774 Mori et al. Apr 2012 B2
8163619 Yang et al. Apr 2012 B2
8169002 Chang et al. May 2012 B2
8170857 Joshi et al. May 2012 B2
8173499 Chung et al. May 2012 B2
8173502 Yan et al. May 2012 B2
8176461 Trimberger May 2012 B1
8178430 Kim et al. May 2012 B2
8179530 Levy et al. May 2012 B2
8183096 Wirbeleit May 2012 B2
8183107 Mathur et al. May 2012 B2
8185865 Gupta et al. May 2012 B2
8187959 Pawlak et al. May 2012 B2
8188542 Yoo et al. May 2012 B2
8196545 Kurosawa Jun 2012 B2
8201122 Dewey, III et al. Jun 2012 B2
8214190 Joshi et al. Jul 2012 B2
8217423 Liu et al. Jul 2012 B2
8225255 Ouyang et al. Jul 2012 B2
8227307 Chen et al. Jul 2012 B2
8236661 Dennard et al. Aug 2012 B2
8239803 Kobayashi Aug 2012 B2
8247300 Babcock et al. Aug 2012 B2
8255843 Chen et al. Aug 2012 B2
8258026 Bulucea Sep 2012 B2
8266567 El Yahyaoui et al. Sep 2012 B2
8273617 Thompson et al. Sep 2012 B2
8286180 Foo Oct 2012 B2
8288798 Passlack Oct 2012 B2
8298901 Foote et al. Oct 2012 B1
8299562 Li et al. Oct 2012 B2
8324059 Guo et al. Dec 2012 B2
8569156 Scudder et al. Oct 2013 B1
20010014495 Yu Aug 2001 A1
20020033511 Babcock et al. Mar 2002 A1
20020042184 Nandakumar et al. Apr 2002 A1
20020151153 Drobny et al. Oct 2002 A1
20030006415 Yokogawa et al. Jan 2003 A1
20030047763 Hieda et al. Mar 2003 A1
20030122203 Nishinohara et al. Jul 2003 A1
20030173626 Burr Sep 2003 A1
20030183856 Wieczorek et al. Oct 2003 A1
20030215992 Sohn et al. Nov 2003 A1
20040051104 Yamashita et al. Mar 2004 A1
20040053457 Sohn Mar 2004 A1
20040075118 Heinemann et al. Apr 2004 A1
20040075143 Bae et al. Apr 2004 A1
20040084731 Matsuda et al. May 2004 A1
20040087090 Grudowski et al. May 2004 A1
20040126947 Sohn Jul 2004 A1
20040175893 Vatus et al. Sep 2004 A1
20040180488 Lee Sep 2004 A1
20050056877 Rueckes et al. Mar 2005 A1
20050106800 Haensch et al. May 2005 A1
20050106824 Alberto et al. May 2005 A1
20050116282 Pattanayak et al. Jun 2005 A1
20050250289 Babcock et al. Nov 2005 A1
20050280075 Ema et al. Dec 2005 A1
20060017100 Bol et al. Jan 2006 A1
20060022270 Boyd et al. Feb 2006 A1
20060024876 Chidambaram Feb 2006 A1
20060049464 Rao Mar 2006 A1
20060068555 Zhu et al. Mar 2006 A1
20060068586 Pain Mar 2006 A1
20060071278 Takao Apr 2006 A1
20060091481 Li et al. May 2006 A1
20060154428 Dokumaci Jul 2006 A1
20060157794 Doyle et al. Jul 2006 A1
20060197158 Babcock et al. Sep 2006 A1
20060203581 Joshi et al. Sep 2006 A1
20060220114 Miyashita et al. Oct 2006 A1
20060223248 Venugopal et al. Oct 2006 A1
20070040222 Van Camp et al. Feb 2007 A1
20070117326 Tan et al. May 2007 A1
20070158790 Rao Jul 2007 A1
20070212861 Chidambarrao et al. Sep 2007 A1
20070238253 Tucker Oct 2007 A1
20080067589 Ito et al. Mar 2008 A1
20080108208 Arevalo et al. May 2008 A1
20080138953 Challa et al. Jun 2008 A1
20080169493 Lee et al. Jul 2008 A1
20080169516 Chung Jul 2008 A1
20080194069 Surdeanu et al. Aug 2008 A1
20080197439 Goerlach et al. Aug 2008 A1
20080199999 Weijtmans et al. Aug 2008 A1
20080227250 Ranade et al. Sep 2008 A1
20080237661 Ranade et al. Oct 2008 A1
20080258198 Bojarczuk et al. Oct 2008 A1
20080272409 Sonkusale et al. Nov 2008 A1
20090003105 Itoh et al. Jan 2009 A1
20090057746 Sugll et al. Mar 2009 A1
20090057762 Bangsaruntip et al. Mar 2009 A1
20090079008 Nandakumar et al. Mar 2009 A1
20090081858 Qin et al. Mar 2009 A1
20090108350 Cai et al. Apr 2009 A1
20090121298 Furukawa et al. May 2009 A1
20090134468 Tsuchiya et al. May 2009 A1
20090179280 Kohli et al. Jul 2009 A1
20090224319 Kohli Sep 2009 A1
20090278209 Noda Nov 2009 A1
20090286367 Krull et al. Nov 2009 A1
20090302388 Cai et al. Dec 2009 A1
20090309140 Khamankar et al. Dec 2009 A1
20090311837 Kapoor Dec 2009 A1
20090321849 Miyamura et al. Dec 2009 A1
20100012988 Yang et al. Jan 2010 A1
20100038724 Anderson et al. Feb 2010 A1
20100078729 Fukutome et al. Apr 2010 A1
20100100856 Mittal Apr 2010 A1
20100133624 Nandakumar et al. Jun 2010 A1
20100148153 Hudait et al. Jun 2010 A1
20100149854 Vora Jun 2010 A1
20100187641 Zhu et al. Jul 2010 A1
20100207182 Paschal Aug 2010 A1
20100270600 Inukai et al. Oct 2010 A1
20100276761 Tung et al. Nov 2010 A1
20110059588 Kang Mar 2011 A1
20110073961 Dennard et al. Mar 2011 A1
20110074498 Thompson et al. Mar 2011 A1
20110079860 Verhulst Apr 2011 A1
20110079861 Shifren et al. Apr 2011 A1
20110095811 Chi et al. Apr 2011 A1
20110147828 Murthy et al. Jun 2011 A1
20110169082 Zhu et al. Jul 2011 A1
20110175140 Taylor et al. Jul 2011 A1
20110175170 Wang et al. Jul 2011 A1
20110180880 Chudzik et al. Jul 2011 A1
20110193164 Zhu Aug 2011 A1
20110212590 Wu et al. Sep 2011 A1
20110230039 Mowry et al. Sep 2011 A1
20110242921 Tran et al. Oct 2011 A1
20110248352 Shifren Oct 2011 A1
20110294278 Eguchi et al. Dec 2011 A1
20110309447 Arghavani et al. Dec 2011 A1
20120021594 Gurtej et al. Jan 2012 A1
20120034745 Colombeau et al. Feb 2012 A1
20120056275 Cai et al. Mar 2012 A1
20120065920 Nagumo et al. Mar 2012 A1
20120108050 Chen et al. May 2012 A1
20120132998 Kwon et al. May 2012 A1
20120138953 Cai et al. Jun 2012 A1
20120146155 Hoentschel et al. Jun 2012 A1
20120161210 Heinrich et al. Jun 2012 A1
20120167025 Gillespie et al. Jun 2012 A1
20120187491 Zhu et al. Jul 2012 A1
20120190177 Kim et al. Jul 2012 A1
20120223363 Kronholz et al. Sep 2012 A1
Foreign Referenced Citations (14)
Number Date Country
0274278 Jul 1988 EP
0312237 Apr 1989 EP
0531621 Mar 1993 EP
0683515 Nov 1995 EP
0889502 Jan 1999 EP
1450394 Aug 2004 EP
59193066 Nov 1984 JP
4186774 Jul 1992 JP
8153873 Jun 1996 JP
8288508 Nov 1996 JP
2004087671 Mar 2004 JP
794094 Jan 2008 KR
WO2005093831 Oct 2005 WO
WO2011062788 May 2011 WO
Non-Patent Literature Citations (33)
Entry
Abiko, H et al., “A Channel Engineering Combined with Channel Epitaxy Optimization and TED Suppression for 0.15μm n-n Gate CMOS Technology”, 1995 Symposium on VLSI Technology Digest of Technical Papers, pp. 23-24, 1995.
Chau, R et al., “A 50nm Depleted-Substrate CMOS Transistor (DST)”, Electron Device Meeting 2001, IEDM Technical Digest, IEEE International, pp. 29.1.1-29.1.4, 2001.
Ducroquet, F et al. “Fully Depleted Silicon-On-Insulator nMOSFETs with Tensile Strained High Carbon Content Si1-yCy Channel”, ECS 210th Meeting, Abstract 1033, 2006.
Ernst, T et al., “Nanoscaled MOSFET Transistors on Strained Si, SiGe, Ge Layers: Some Integration and Electrical Properties Features”, ECS Trans. 2006, vol. 3, Issue 7, pp. 947-961.
Goesele, U et al., Diffusion Engineering by Carbon in Silicon, Mat. Res. Soc. Symp. vol. 610, 2000.
Hokazono, A et al., “Steep Channel & Halo Profiles Utilizing Boron-Diffusion-Barrier Layers (Si:C) for 32 nm Node and Beyond”, 2008 Symposium on VLSI Technology Digest of Technical Papers, pp. 112-113, 2008.
Hokazono, A et al., “Steep Channel Profiles in n/pMOS Controlled by Boron-Doped Si:C Layers for Continual Bulk-CMOS Scaling”, IEDM09-676 Symposium, pp. 29.1.1-29.1.4, 2009.
Holland, OW and Thomas, DK “A Method to Improve Activation of Implanted Dopants in SiC”, Oak Ridge National Laboratory, Oak Ridge, TN, 2001.
Kotaki, H., et al., “Novel Bulk Dynamic Threshold Voltage MOSFET (B-DTMOS) with Advanced Isolation (SITOS) and Gate to Shallow-Well Contact (SSS-C) Processes for Ultra Low Power Dual Gate CMOS”, IEDM 96, pp. 459-462, 1996.
Lavéant, P. “Incorporation, Diffusion and Agglomeration of Carbon in Silicon”, Solid State Phenomena, vols. 82-84, pp. 189-194, 2002.
Noda, K et al., “A 0.1-μm Delta-Doped MOSFET Fabricated with Post-Low-Energy Implanting Selective Epitaxy” IEEE Transactions on Electron Devices, vol. 45, No. 4, pp. 809 -814, Apr. 1998.
Ohguro, T et al., “An 0.18-μm CMOS for Mixed Digital and Analog Aplications with Zero-Volt-Vth Epitaxial-Channel MOSFET's”, IEEE Transactions on Electron Devices, vol. 46, No. 7, pp. 1378-1383, Jul. 1999.
Pinacho, R et al., “Carbon in Silicon: Modeling of Diffusion and Clustering Mechanisms”, Journal of Applied Physics, vol. 92, No. 3, pp. 1582-1588, Aug. 2002.
Robertson, LS et al., “The Effect of Impurities on Diffusion and Activation of Ion Implanted Boron in Silicon”, Mat. Res. Soc. Symp. vol. 610, 2000.
Scholz, Ret al., “Carbon-Induced Undersaturation of Silicon Self-Interstitials”, Appl. Phys. Lett. 72(2), pp. 200-202, Jan. 1998.
Scholz, RF et al., “The Contribution of Vacancies to Carbon Out-Diffusion in Silicon”, Appl. Phys. Lett., vol. 74, No. 3, pp. 392-394, Jan. 1999.
Stolk, PA et al., “Physical Mechanisms of Transient Enhanced Dopant Diffusion in Ion-Implanted Silicon”, J. Appl. Phys. 81(9), pp. 6031-6050, May 1997.
Thompson, S et al., “MOS Scaling: Transistor Challenges for the 21st Century”, Intel Technology Journal Q3′ 1998, pp. 1-19, 1998.
Wann, C. et al., “Channel Profile Optimization and Device Design for Low-Power High-Performance Dynamic-Threshold MOSFET”, IEDM 96, pp. 113-116, 1996.
Werner, P. et al., “Carbon Diffusion in Silicon”, Applied Physics Letters, vol. 73, No. 17, pp. 2465-2467, Oct. 1998.
Yan, Ran-Hong et al., “Scaling the Si MOSFET: From Bulk to SOI to Bulk”, IEEE Transactions on Electron Devices, vol. 39, No. 7, Jul. 1992.
Shao, et al., “Boron Diffusion in Silicon: The Anomalies and Control by Point Defect Engineering”, Materials Science and Engineering R: Reports, vol. 42, No. 3-4, pp. 65-114, Nov. 1, 2003.
Banerjee, et al. “Compensating Non-Optical Effects using Electrically-Driven Optical Proximity Correction”, Proc. of SPIE vol. 7275 7275OE, 2009.
Cheng, et al. “Extremely Thin SOI (ETSOI) CMOS with Record Low Variability for Low Power System-on-Chip Applications”, Electron Devices Meeting (IEDM), Dec. 2009.
Cheng, et al. “Fully Depleted Extremely Thin SOI Technology Fabricated by a Novel Integration Scheme Feturing Implant-Free, Zero-Silicon-Loss, and Faceted Raised Source/Drain”, Symposium on VLSI Technology Digest of Technical Papers, pp. 212-213, 2009.
Drennan, et al. “Implications of Proximity Effects for Analog Design”, Custom Integrated Circuits Conference, pp. 169-176, Sep. 2006.
Hook, et al. “Lateral Ion Implant Straggle and Mask Proximity Effect”, IEEE Transactions on Electron Devices, vol. 50, No. 9, pp. 1946-1951, Sep. 2003.
Hori, et al., “A 0.1 μm CMOS with a Step Channel Profile Formed by Ultra High Vacuum CVD and In-Situ Doped Ions”, Proceedsing of the International Electron Devices Meeting, New York, IEEE, US, pp. 909-911, Dec. 5, 1993.
Matshuashi, et al. “High-Performance Double-Layer Epitaxial-Channel PMOSFET Compatible with a Single Gate CMOSFET”, Symposium on VLSI Technology Digest of Technical Papers, pp. 36-37, 1996.
Sheu, et al. “Modeling the Well-Edge Proximity Effect in Highly Scaled MOSFETs”, IEEE Transactions on Electron Devices, vol. 53, No. 11, pp. 2792-2798, Nov. 2006.
Komaragiri, R. et al., “Depletion-Free Poly Gate Electrode Architecture for Sub 100 Nanometer CMOS Devices with High-K Gate Dielectrics”, IEEE IEDM Tech Dig., San Francisco CA, 833-836, Dec. 13-15, 2004.
Samsudin, K et al., “Integrating Intrinsic Parameter Fluctuation Description into BSIMSOI to Forecast sub-15nm UTB SOI based 6T SRAM Operation”, Solid-State Electronics (50), pp. 86-93, 2006.
Wong, H et al., “Nanoscale CMOS”, Proceedings of the IEEE, Vo. 87, No. 4, pp. 537-570, Apr. 1999.